Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-008499
Filing Date
2025-08-13
Accepted
2025-08-13 12:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27738
2 filename2.txt TEXT-EXTRACT 1232
  Complete submission text file 0000000000-25-008499.txt   40193
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filed for) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-289365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)